Residual clinical samples represent a very appealing source of biomaterial for translational and clinical research. We describe the implementation of an opt-in biobank, with consent being obtained at the time of registration and the decision stored in our electronic health record, Epic. Information on that decision, along with laboratory data, is transferred to an application that signals to biobank staff whether a given sample can be kept for research. Investigators [...]
Author(s): Marsolo, Keith, Corsmo, Jeremy, Barnes, Michael G, Pollick, Carrie, Chalfin, Jamie, Nix, Jeremy, Smith, Christopher, Ganta, Rajesh
DOI: 10.1136/amiajnl-2012-000960